News & Updates
Filter by Specialty:
COVID-19 may trigger hair, nail disorders
Hair and nail disorders may occur following contraction of COVID-19 infection, with the development of the dermatological conditions related to a history of severe infection, a study has found.
COVID-19 may trigger hair, nail disorders
21 Nov 2022
Biologics prevent infection-related hospitalization in IBD patients with comorbidity
Treatment with vedolizumab or ustekinumab leads to reduced rates of infection-related hospitalization compared with antitumour necrosis factor-α antagonists (anti-TNF) among adults with inflammatory bowel disease (IBD) initiating biologic therapy and with high comorbidity burden, reports a recent study.
Biologics prevent infection-related hospitalization in IBD patients with comorbidity
20 Nov 2022
High-flow oxygen does not reduce mortality in COVID-19 respiratory failure
The use of high-flow nasal cannula oxygen, as opposed to standard oxygen, in the first-line setting, did not reduce mortality rates in patients admitted to intensive care units (ICUs) for respiratory failure due to COVID-19, results of the SOHO-COVID trial showed.
High-flow oxygen does not reduce mortality in COVID-19 respiratory failure
20 Nov 2022
CRT vs SBRT: Which approach yields better outcomes in PDAC?
Multiagent chemotherapy (MAC) followed by conventionally fractionated radiotherapy (CRT) shows rates of margin-negative resection (R0) and pathologic complete response similar to those of MAC plus stereotactic body radiotherapy (SBRT) in patients with localized pancreatic ductal adenocarcinoma (PDAC), according to a study. However, MAC plus CRT is associated with less regional lymphatic disease.
CRT vs SBRT: Which approach yields better outcomes in PDAC?
20 Nov 2022
H. pylori eradication eases metabolic dysfunction, steatosis in NAFLD
Among patients with nonalcoholic fatty liver disease (NAFLD), eradication treatment against Helicobacter pylori may help improve liver steatosis and metabolic parameters, a recent study has found.
